S H Kelkar and Company growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+11.5%+10.0%+14.4%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−18.6%−3.2%+41.2%
−39.5%−7.0%+58.9%
−5.3%−40.9%+96.3%
−5.8%−40.5%+97.1%
+8.5%+11.8%+8.1%
+7.1%+4.8%+10.1%
+1,571.7%−85.4%−43.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHK₹125.00

S H Kelkar and Company Limited

· Chemicals
₹ CrorePeersATULANURASBAYERCROPCAMLINFINESWANCORPCLEANDEEPAKNTRTIRUMALCHMMcap ₹1,730 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+14.4+10.0+11.5—
EBITDA Growth—+41.2-3.2-18.6—
EBIT Growth—+58.9-7.0-39.5—
Net Income Growth—+96.3-40.9-5.3—
EPS Growth—+97.1-40.5-5.8—
Total Assets Growth—+8.1+11.8+8.5—
Total Equity Growth—+10.1+4.8+7.1—
Cash from Operations Growth—-43.3-85.4+1,571.7—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.